📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR. (2021)

First Author: Selvaraj M

Attributed to: High Containment funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/v13112320

PubMed Identifier: 34835126

Publication URI: http://europepmc.org/abstract/MED/34835126

Type: Journal Article/Review

Volume: 13

Parent Publication: Viruses

Issue: 11

ISSN: 1999-4915